Visualitza per autor "Álvarez Román, María Teresa"
Ara mostrant els elements 1-5 d 5
-
Clinical Efficacy and Safety of Fanhdi®, a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
Jiménez-Yuste, Víctor; Palomo Bravo, Ángeles; Galmes, Bernardo J.; Nieto Hernández, Maria del Mar; Benitez Hidalgo, Olga; Álvarez Román, María Teresa (SAGE Publications, 2022-01) -
Determining the value contribution of emicizumab (Hemlibra®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis
Cuervo-Arango, Ignacio; Pérez-Santamarina, Rafael; Poveda, José Luís; Romero, José Antonio; Santamaría Ortiz, Amparo; Álvarez Román, María Teresa (SAGE Publications, 2019-10-08) -
Elucidating the Mechanism of Action of the Attributed Immunomodulatory Role of Eltrombopag in Primary Immune Thrombocytopenia: An In Silico Approach
Lozano, Maria L.; Segú-Vergés, Cristina; Coma, Mireia; González-Porras, José R.; Gutiérrez, Laura; Valcarcel Ferreiras, David; Álvarez Román, María Teresa (MDPI, 2021-07) -
Management of adult patients with primary immune thrombocytopenia (ITP) in clinical practice: a consensus approach of the Spanish ITP expert group
Fernández Fuertes, Luis Fernando; González-López, Tomás José; Guinea de Castro, José María; Valcarcel Ferreiras, David; Mingot-Castellano, M.E.; Álvarez Román, María Teresa; Jarque, Isidro (Hindawi, 2019-08-22) -
Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI)
Canaro Hirnyk, Mariana ; Sánchez-González, Blanca; Álvarez Román, María Teresa; Bárez-García, Abelardo; Bernardo, Angel; Mingot Castellano, María Eva; VALCARCEL, DAVID (MDPI, 2023-10-10)